These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38965696)

  • 1. Use of Maternal Race and Weight Provides Equitable Performance in Serum Screening for Open Neural Tube Defects.
    Messerlian G; Strickland SW; Willbur J; Vaughan C; Koenig S; Wright T; Palomaki GE
    Clin Chem; 2024 Jul; 70(7):948-956. PubMed ID: 38965696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-fetoprotein concentrations in maternal serum: relation to race and body weight.
    Crandall BF; Lebherz TB; Schroth PC; Matsumoto M
    Clin Chem; 1983 Mar; 29(3):531-3. PubMed ID: 6186415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reconsidering Race Adjustment in Prenatal Alpha-Fetoprotein Screening.
    Burns RN; Kolarova T; Katz R; Ma K; Delaney S
    Obstet Gynecol; 2023 Mar; 141(3):438-444. PubMed ID: 36735409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory screening and diagnosis of open neural tube defects, 2019 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG).
    Palomaki GE; Bupp C; Gregg AR; Norton ME; Oglesbee D; Best RG;
    Genet Med; 2020 Mar; 22(3):462-474. PubMed ID: 31700163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of incorrect gestational dating on Down's syndrome and neural tube risk assessment.
    Millner SN
    Ann Clin Biochem; 2001 May; 38(Pt 3):230-4. PubMed ID: 11392497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of estimating gestational age by ultrasound cephalometry on the specificity of alpha-fetoprotein screening for open neural-tube defects.
    Wald N; Cuckle H; Boreham J; Turnbull AC
    Br J Obstet Gynaecol; 1982 Dec; 89(12):1050-3. PubMed ID: 6184069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is maternal alpha-fetoprotein screening still of value in a low-risk area for neural tube defects?
    Hooker JG; Lucas M; Richards BA; Shirley IM; Thompson BD; Ward RH
    Prenat Diagn; 1984; 4(1):29-33. PubMed ID: 6203108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of allowing for ethnic group in prenatal screening for Down's syndrome.
    Watt HC; Wald NJ; Smith D; Kennard A; Densem J
    Prenat Diagn; 1996 Aug; 16(8):691-8. PubMed ID: 8878277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal serum alpha-fetoprotein levels in pregnancies among black and white women with fetal open spina bifida: a United States collaborative study.
    Johnson AM; Palomaki GE; Haddow JE
    Am J Obstet Gynecol; 1990 Feb; 162(2):328-31. PubMed ID: 1689960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New cut-off values for screening of trisomy 21, 18 and open neural tube defects (ONTD) during the second trimester in pregnant women with advanced maternal age.
    Chen Y; Wang X; Li L; Lu S; Zhang Z
    BMC Pregnancy Childbirth; 2020 Dec; 20(1):776. PubMed ID: 33317474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-fetoprotein detection of neural tube defects and the impact of standard ultrasound.
    Dashe JS; Twickler DM; Santos-Ramos R; McIntire DD; Ramus RM
    Am J Obstet Gynecol; 2006 Dec; 195(6):1623-8. PubMed ID: 16769022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assay precision of serum alpha fetoprotein in antenatal screening for neural tube defects and Down's syndrome.
    Wald NJ; Hackshaw AK; George LM
    J Med Screen; 2000; 7(2):74-7. PubMed ID: 11002446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction and predictive value of risk models of maternal serum alpha-fetoprotein variants and fetal open neural tube defects.
    Chen Y; Wang X; Chen Y; Ning W; Chen L; Yin Y; Zhang W; Lian J; Wang H
    Exp Biol Med (Maywood); 2022 May; 247(10):822-831. PubMed ID: 35238224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The diagnostic accuracy of maternal serum alpha-fetoprotein variants (AFP-L2 and AFP-L3) in predicting fetal open neural tube defects and abdominal wall defects.
    Chen Y; Wang X; Lu S; Huang J; Zhang L; Hu W
    Clin Chim Acta; 2020 Aug; 507():125-131. PubMed ID: 32251652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of a serum screening service for neural-tube defects: the South Wales experience.
    Roberts CJ; Hibbard BM; Elder GH; Evans KT; Laurence KM; Roberts A; Woodhead JS; Robertson IB; Hoole M
    Lancet; 1983 Jun; 1(8337):1315-8. PubMed ID: 6190057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prenatal detection of open neural tube defects in a mass screening program by determination of alpha-fetoprotein concentration in maternal serum].
    Zwahr C; Körner H; Tinschert S; Horn A; Schulze M; Voigt M
    Zentralbl Gynakol; 1988; 110(3):158-67. PubMed ID: 2452529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down syndrome and neural tube defect screening: the value of using gestational age by ultrasonography.
    Benn PA; Borgida A; Horne D; Briganti S; Collins R; Rodis JF
    Am J Obstet Gynecol; 1997 May; 176(5):1056-61. PubMed ID: 9166168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First-trimester screening for neural tube defects using alpha-fetoprotein.
    Bredaki FE; Poon LC; Birdir C; Escalante D; Nicolaides KH
    Fetal Diagn Ther; 2012; 31(2):109-14. PubMed ID: 22377693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triple marker screening for trisomy 21, trisomy 18 and open neural tube defects in singleton pregnancies of native Japanese pregnant women.
    Onda T; Tanaka T; Yoshida K; Nakamura Y; Kudo R; Yamamoto H; Sato A; Yanagida K; Takai Y; Uemura H; Hoshi K; Fukada Y; Miyake Y; Ohnishi M; Kaneoka T; Makino Y; Murata Y; Kanzaki T; Kanzaki H; Osaki T; Aono T; Maeda K; Ogita S; Yamamasu S; Aso T; Shimizu Y; Izutsu T; Kudo T; Okai T; Sakai M; Hashimoto T; Matsuzaki N; Kitagawa M; Sago H; Grier RE; Myrick F; Shimizu Y
    J Obstet Gynaecol Res; 2000 Dec; 26(6):441-7. PubMed ID: 11152330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.